Patents by Inventor Chantal Furstner

Chantal Furstner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclylmethyl-substituted pyrazol derivatives
    Patent number: 6410740
    Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: June 25, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Alexander Straub, Chantal Fürstner, Ulrich Niewöhner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Dieter Arlt
  • Heterocyclylmethyl-substituted pyrazole derivatives
    Patent number: 6387940
    Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: May 14, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Alexander Straub, Chantal Fürstner, Ulrich Niewöhner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hütter, Klaus Dembowsky, Dieter Arlt
  • 2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases
    Patent number: 6344471
    Abstract: The present invention relates to novel 2-aminocarbonyl-5(2H)-isoxazolones as selective ligands of a high-affinity binding site of diisopropyl fluorophosphate (DFP) on brain membranes for the prophylaxis and treatment of disorders of the central nervous system, in particular cognitive disorders, depression, schizophrenia and anxiety.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: February 5, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Stephan Lensky, Bernd Riedl, Chantal Fürstner, Jens Ergüden, Frank Böss, Bernhard Schmidt, Franz-Josef van der Staay, Werner Schröder, Joachim Schuhmacher, Delf Schmidt
  • Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
    Patent number: 6166027
    Abstract: The present invention relates to new heterocyclylmethyl-substituted pyrazole derivatives, processes for their preparation and their use as medicaments, in particular as medicaments for treatment of cardiovascular diseases.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: December 26, 2000
    Assignee: Bayer Aktiengesellschaft
    Inventors: Alexander Straub, Chantal Furstner, Ulrich Niewohner, Thomas Jaetsch, Achim Feurer, Raimund Kast, Johannes-Peter Stasch, Elisabeth Perzborn, Joachim Hutter, Klaus Dembowsky, Dieter Arlt